- Home
- WEA vs TNYA Comparison
WEA vs TNYA Comparison
Compare WEA & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WEA
- TNYA
- Stock Information
- Founded
- WEA 2002
- TNYA 2016
- Country
- WEA United States
- TNYA United States
- Employees
- WEA N/A
- TNYA N/A
- Industry
- WEA Trusts Except Educational Religious and Charitable
- TNYA Medicinal Chemicals and Botanical Products
- Sector
- WEA Finance
- TNYA Health Care
- Exchange
- WEA Nasdaq
- TNYA Nasdaq
- Market Cap
- WEA 131.0M
- TNYA 138.1M
- IPO Year
- WEA N/A
- TNYA 2021
- Fundamental
- Price
- WEA $11.08
- TNYA $2.16
- Analyst Decision
- WEA
- TNYA Strong Buy
- Analyst Count
- WEA 0
- TNYA 5
- Target Price
- WEA N/A
- TNYA $14.75
- AVG Volume (30 Days)
- WEA 46.1K
- TNYA 5.4M
- Earning Date
- WEA 01-01-0001
- TNYA 11-06-2024
- Dividend Yield
- WEA 7.87%
- TNYA N/A
- EPS Growth
- WEA N/A
- TNYA N/A
- EPS
- WEA N/A
- TNYA N/A
- Revenue
- WEA N/A
- TNYA N/A
- Revenue This Year
- WEA N/A
- TNYA N/A
- Revenue Next Year
- WEA N/A
- TNYA $359.94
- P/E Ratio
- WEA N/A
- TNYA N/A
- Revenue Growth
- WEA N/A
- TNYA N/A
- 52 Week Low
- WEA $9.60
- TNYA $1.61
- 52 Week High
- WEA $11.29
- TNYA $7.01
- Technical
- Relative Strength Index (RSI)
- WEA 49.01
- TNYA 50.71
- Support Level
- WEA $10.97
- TNYA $1.91
- Resistance Level
- WEA $11.26
- TNYA $2.51
- Average True Range (ATR)
- WEA 0.18
- TNYA 0.36
- MACD
- WEA 0.00
- TNYA -0.01
- Stochastic Oscillator
- WEA 37.14
- TNYA 20.49
About WEA Western Asset Bond Fund Share of Beneficial Interest
Western Asset Premier Bond Fund is a diversified, closed-end management investment company. Its investment objective is to provide current income and capital appreciation by investing in a diversified portfolio of investment-grade bonds. The Fund invests in sectors, such as financials, energy, telecommunication services, consumer discretionary, healthcare, materials, information technology, and consumer staples.
About TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration, and precision medicine.